Outset Medical announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.
Investing.com -- Outset Medical Inc (NASDAQ:OM) stock jumped 9% in premarket trading Tuesday after the medical technology company announced FDA clearance for its next-generation Tablo dialysis ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する